Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Clinical trial NCT06842199 · RECRUITING

Trial details

NCT number: NCT06842199
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis Patients

Start date: 2025-03-20
Primary completion: 2026-05-01
Enrollment: 383

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.